Abiomed Recovering Hearts. Saving Lives
Our Company Investors News Products Clinicians Patients & Families

 

 

 

Easy to Use & Minimally Invasive

The Impella 2.5 is a minimally invasive, catheter-based cardiac assist device designed to:

  • Directly unload the left ventricle
  • Reduce myocardial workload and oxygen consumption
  • Increase cardiac output and coronary and end-organ perfusion

The Impella 2.5 can be inserted into the left ventricle in a Cath Lab via a standard guidewire through the femoral artery, into the ascending aorta, across the valve and into the left ventricle.The tip of the catheter contains a “pigtail” that crosses the patient’s heart valve and rests in the left ventricle, generating flows up to 2.5 L/min.

Proven Breakthrough Technolgoy

The Impella 2.5 has been used to provide partial  circulatory support in over 1000 patients in the U.S. Results from these experiences include:

  • Ease of Placement and Operation
  • Hemocompatible
  • No compromise to valve function
  • Improved limb and tissue perfusion
  • Low Hemolysis, bleeding, and stroke rates
  • Restored Hemodynamics
  • Improved outcomes
  • Unloading effect on the left ventricle

 

Economic Advantage

  • Established Medicare Reimbursement codes
  • Procedure code 37.68: Insertion of a percutaneous heart assist device
  • Proactive reimbursement technical support including sample letters, codes, contacts, and case studies

* Average of DRG 104, 216, 217, 218.
Reimbursement varies by geography.

 

Interested in Participating in the Pivotal Trials for High Risk PCI and AMI? Click here

Click Here to View TCT 2009 Presentations

Downloads